Results 21 to 30 of about 8,266 (211)
Minoxidil in androgenic alopecia: New formulations with Improved delivery [PDF]
المجلة العراقية للصيدلة, 2022 Background: Minoxidil was introduced into the market as a hypotensive agent, however, aftermarketing, the hypertrichosis side effect was reported by almost all users. This adverse effect encourages the repositioning or repurposing the use of minoxidil as
Alaa Al-taie +2 more
doaj +1 more source
Southern Medical Journal, 1980 Minoxidil (U-10,858) has been shown in several controlled and blind studies and numerous uncontrolled studies to be a potent peripheral vasodilator for use in the management of sustained, severe, accelerating or malignant hypertension and moderate hypertension inadequately controlled by conventional therapy.
+6 more sources
Medicine in Drug Discovery, 2020 Aims: Minoxidil is a hair growth drug for treating androgenetic alopecia. Although minoxidil is generally administered as a topical formulation, this prodrug must be converted to its active form (minoxidil sulfate) by sulfotransferase in hair follicle ...
Mio Ichida +4 more
doaj +1 more source
Pharmaceutics, 2022 The purpose of this study was to evaluate mechanisms behind the intestinal permeability of minoxidil, with special emphasis on paracellular transport, and elucidate the suitability of minoxidil to be a reference drug for Biopharmaceutics Classification ...
Milica Markovic +6 more
doaj +1 more source
Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy? [PDF]
Journal of Clinical and Diagnostic Research, 2016 Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions.
Habibullah Aktas +3 more
doaj +1 more source
Dermatologic Therapy, 2022 Alopecia areata (AA), a polygenic and chronic autoimmune disease and there is no definitive cure. We aimed to evaluate latanoprost effects in patients with AA.
Mohammadreza Ghassemi +4 more
doaj +1 more source
Minoxidil and Dexamethasone Eluting Nanofiber Dressing for Cutaneous Wound Healing in Rat [PDF]
Pharmaceutical Sciences, 2023 Background: Minoxidil is an antihypertensive agent and vasodilator which may help to promote local blood flow thus hastening the closure of excisional skin wounds. Corticosteroids may down-regulate wound healing.
Saber khozan +4 more
doaj +1 more source
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2023 The treatment and prevention of hair loss have been a serious aesthetic problem for the population for a long time due to the widespread occurrence of the condition and its undesirable medical and social consequences.
V. V. Hladyshev +6 more
doaj +1 more source
MONILETHRIX TREATED WITH MINOXIDIL [PDF]
, 2011 In literature many different therapies are proposed to treat Monilethrix, but a definitive therapy still doe not exist. We decided to treat four patients affected by Monilethrix, with topical minoxidil 2%, 1 ml night and day for 1 year.
A. Iorio +12 more
core +1 more source
Oral Minoxidil for Androgenetic Alopecia
, 2022 Purpose: The purpose of this article is to review the current treatment options of androgenetic alopecia and to explore the risk and potential benefits of oral Minoxidil therapy.
Ingram, Laurice D
core +1 more source